Platelet Lysates Produced from Expired Platelet Concentrates Support Growth and Osteogenic Differentiation of Mesenchymal Stem Cells

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Jonsdottir Buch, Sandra Mjoll ^a,b   Lieder, Ramona ^a,c   Sigurjonsson, Olafur Eysteinn ^a,b,c  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c REYKJAVIK UNIVERSITY   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR RUNX2;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENETIC MARKER; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MESENCHYMAL STEM CELL; PLATELET LYSATE; RUNX2 GENE; UPREGULATION;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL EXTRACTS; CULTURE MEDIA; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS;

EID: 84880066225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068984     Document Type: Article

References (47)

1. Harmening DM, Escobar CE, McGlasson DL (2009) Introduction to hemostasis. In: Harmening DM, editor. Clinical hematology and fundamentals of hemostasis. Philadelphia: F.A. Davis Company. 543-576.
2. Liles DK, Knupp C (2009) Disorders of Primary Hemostasis: Quantitative and Qualitative Platelet Disorders and Vascular Disorders. In: Harmening DM, editor. Clinical hematology and fundamentals of hemostasis. Philadelphia: F.A. Davis Company. 577-606.
3. Biousse V, (2003) The Coagulation System. J Neuroophthalmol 23: 50-62.
4. Freireich EJ, (2011) Origins of platelet transfusion therapy. Transfus Med Rev 25: 252-256.
5. Redler LH, Thompson SA, Hsu SH, Ahmad CS, Levine WN, (2011) Platelet-Rich Plasma Therapy: A Systematic Literature Review and Evidence For Clinical Usw. Phys Sportsmed 39: 42-51.
6. Burnouf T, Goubran HA, Chen T-M, Ou K-L, El-Ekiaby M,et al. (2013) Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev. doi:10.1016/j.blre.2013.02.001.
7. De Leon JM, Driver VR, Fylling CP, Carter MJ, Anderson C, et al. (2011) The Clinical Relevance of Treating Chronic Wounds with an Enhanced Near-Physiological Concentration of Platelet-Rich Plasma Gel. Adv Skin Wound Care 24: 357-368.
8. Rauch C, Feifel E, Amann E-M, Spötl HP, Schennach H, et al. (2011) Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media. Altex 28: 305-316.
9. Brinchmann JE, (2008) Expanding autologous multipotent mesenchymal bone marrow stromal cells. J Neurol Sci 265: 127-130.
10. Warnke PH, Humpe A, Strunk D, Stephens S, Warnke F, et al. (2013) A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies. J Craniomaxillofac Surg 41: 153-161.
11. Bieback K, Hecker A, Kocaömer A, Lannert H, Schallmoser K, et al. (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27: 2331-2341.
12. Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, et al. (2008) Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 14: 185-196.
13. Sensebé L, (2008) Clinical grade production of mesenchymal stem cells. Biomed Mater Eng 18: 3-10.
14. Even MS, Sandusky CB, Barnard ND, (2006) Serum-free hybridoma culture: ethical, scientific and safety considerations. Trends Biotechnol 24: 105-108.
15. Van der Valk J, Brunner D, De Smet K, Fex Svenningsen A, Honegger P, et al. (2010) Optimization of chemically defined cell culture media-replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro 24: 1053-1063.
16. Weiss RA, (2003) Cross-species infections. Curr Top Microbiol Immunol 278: 47-71.
17. Schallmoser K, Strunk D, (2013) Generation of a Pool of Human Platelet Lysate and Efficient Use in Cell Culture. In: Helgason CD, Miller CL, editors. Basic Cell Culture Protocols, Methods in Molceular Biology. Totowa, NJ: Humana Press, Vol. 946: 349-362.
18. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, et al. (2007) Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47: 1436-1446.
19. Riley W, Schwei M, Mccullough J, (2007) The United States' potential blood donor pool: estimating the prevalence of donor-exclusion factors on the pool of potential donors. Transfusion 47: 1180-1188.
20. Verma A, Agarwal P, (2009) Platelet utilization in the developing world: Strategies to optimize platelet transfusion practices. Transfus Apher Sci 41: 145-149.
21. Murphy WG, Foley M, Doherty C, Tierney G, Kinsella A, et al. (2008) Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 95: 13-19.
22. Dumont LJ, VandenBroeke T, (2003) Seven-day storage of apheresis platelets: report of an in vitro study. Transfusion 43: 143-150.
23. Sweeney J, (1998) Quality Assurance and Standards for Red Cells and Platelets. Vox Sang 74: 201-205.
24. Pretheeban T, Paylor B, Zhang R (2012) Role of stem/progenitor cells in reparative disorders. Fibrogenesis Tissue Repair. doi:10.1186/1755-1536-5-20.
25. Sources C, Engineering BT, Science B, (2011) Cell Sources for Bone Tissue Engineering: Insights from Basic Science. Tissue Eng Part B Rev 17: 449-457.
26. Filardo G, Madry H, Jelic M, Roffi A, Cucchiarini M,et al. (2013) Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics. Knee Surg Sports Traumatol Arthrosc. doi:10.1007/s00167-012-2329-3.
27. Jimi E, Hirata S, Osawa K, Terashita M, Kitamura C,et al. (2012) The Current and Future Therapies of Bone Regeneration to Repair Bone Defects. Int J Dent. doi:10.1155/2012/148261.
28. Temeno JS, Mikos AG, (2000) Review: tissue engineering for regeneration of articular cartilage. Biomaterials 21: 431-440.
29. Le Blank K, Götherström C, Ringdén O, Hassan M, McMahon R, et al. (2005) Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79: 1607-1614.
30. Nöth U, Steinert AF, Tuan RS, (2008) Technology Insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol 4: 371-380.
31. Frey P, Seefried L, Benisch P, Schilling T, Klein-hitpass L, et al. (2012) The Transcriptional Profile of Mesenchymal Stem Cell Populations in Primary Osteoporosis Is Distinct and Shows Overexpression of Osteogenic Inhibitors. PLoS One 7: e45142.
32. Laar JM Van, Tyndall A, (2006) Adult stem cells in the treatment of autoimmune diseases. Rheumatology 45: 1187-1193.
33. Le Blanc K, Rasmusson I, Sundberg B, Hassan M, Uzunel M, (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. The Lancet 363: 1439-1441.
34. Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, et al. (2007) Mesenchymal Stem Cells Effectively Modulate Pathogenic Immune Response in Experimental Autoimmune Encephalomyelitis. Ann Neurol 61: 219-227.
35. Pérez-ilzarbe M, Díez-campelo M, Aranda P, Tabera S, Lopez T, et al. (2009) Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion 49: 1901-1910.
36. Al-Nbaheen M, Ali D, Bouslimi A, Al-jassir F, Adjaye J, et al. (2013) Human Stromal (Mesenchymal) Stem Cells from Bone Marrow, Adipose Tissue and Skin Exhibit Differences in Molecular Phenotype and Differentiation Potential. Stem Cell Rev 9: 32-43.
37. Fernandez VB, Romaniuk MA, Choi H, Labovsky V, Otaegui J, et al. (2013) Mesenchymal stem cells and their use in therapy: What has been achieved? Differentiation 85: 1-10.
38. Hao L, Sun H, Wang J, Wang T, (2011) Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis. Int J Hematol 95: 34-46.
39. Daubert EA, Condron BG, (2010) Serotonin: a regulator of neuronal morphology and circuitry. Trends Neurosci 33: 424-434.
40. Bliziotes M, (2010) Update in Serotonin and Bone. J Clin Endocrinol Metab 95: 4124-4132.
41. Gustafsson BI, Thommesen L, Stunes A, Thommeras K, Westbroek I, et al. (2006) Seretonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 98: 139-151.
42. Horn P, Bokermann G, Cholewa D, Bork S, Walenda T, et al. (2010) Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 12: 888-898.
43. Cholewa D, Stiehl T, Schellenberg A, Bokermann G, Joussen S, et al. (2011) Expansion of adipose mesenchymal stromal cells is affected by human platelet lysates and plating density. Cell Transplant 20: 1409-1422.
44. Le Blanc K, Ringde O, (2007) Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262: 509-525.
45. Uccelli A, Moretta L, Pistoia V, (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-737.
46. Eriksen EF, (2010) Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord 11: 219-227.
47. Pösel C, Möller K, Fröhlich W, Schulz I, Boltze J, et al. (2012) Density gradient centrifugation compromises bone marrow mononuclear cell yield. PloS one 7: e50293.